25 March 2017
News and Views
Links and Services
The latest issue of Gut investigates intrauterine exposure and the pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Several studies have demonstrated a favourable safety profile for thiopurine use for inflammatory
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors